B.Riley Resumes Harrow Health (HROW) at Buy

October 14, 2021 7:22 AM EDT Send to a Friend
B.Riley analyst Justin Walsh resumes coverage on Harrow Health (NASDAQ: HROW) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login